Home > Journals > International Angiology > Past Issues > International Angiology 2017 October;36(5) > International Angiology 2017 October;36(5):496-7

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

LETTERS TO THE EDITOR   Freefree

International Angiology 2017 October;36(5):496-7

DOI: 10.23736/S0392-9590.17.03819-6

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Extended use of sulodexide, apixaban, rivaroxaban and dabigatran in venous thromboembolism: indirect comparison of clinical trials

Witold TOMKOWSKI 1, Paweł KUCA 1 , Angelo A. BIGNAMINI 2, Giseppe M. ANDREOZZI 3

1 Polish Foundation against Thrombosis, National Tuberculosis and Lung Diseases Research Institute, Cardio-Pulmonary Intensive Care, Warsaw, Poland; 2 School of Specialization in Hospital Pharmacy, Department of Pharmaceutical Sciences, University of Milan, Milan, Italy; 3 Unit of Angiology, University Hospital, Padua, Italy


PDF


top of page